STEAMBOAT

Welcome to the Brand page for “STEAMBOAT”, which is offered here for Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders;pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “STEAMBOAT” is believed to be currently owned by “Neurocrine Biosciences, Inc.”


Owner:
NEUROCRINE BIOSCIENCES, INC.
Owner Details
Description:
Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders;Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders;
Categories: PROVIDING MEDICAL INFORMATION RELATING